These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14663034)

  • 1. A CAV3 microdeletion differentially affects skeletal muscle and myocardium.
    Cagliani R; Bresolin N; Prelle A; Gallanti A; Fortunato F; Sironi M; Ciscato P; Fagiolari G; Bonato S; Galbiati S; Corti S; Lamperti C; Moggio M; Comi GP
    Neurology; 2003 Dec; 61(11):1513-9. PubMed ID: 14663034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease.
    Kubisch C; Schoser BG; von Düring M; Betz RC; Goebel HH; Zahn S; Ehrbrecht A; Aasly J; Schroers A; Popovic N; Lochmüller H; Schröder JM; Brüning T; Malin JP; Fricke B; Meinck HM; Torbergsen T; Engels H; Voss B; Vorgerd M
    Ann Neurol; 2003 Apr; 53(4):512-20. PubMed ID: 12666119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel CAV3 gene mutations in Japanese families.
    Sugie K; Murayama K; Noguchi S; Murakami N; Mochizuki M; Hayashi YK; Nonaka I; Nishino I
    Neuromuscul Disord; 2004 Dec; 14(12):810-4. PubMed ID: 15564037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders.
    Gazzerro E; Bonetto A; Minetti C
    Handb Clin Neurol; 2011; 101():135-42. PubMed ID: 21496630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease.
    Sotgia F; Woodman SE; Bonuccelli G; Capozza F; Minetti C; Scherer PE; Lisanti MP
    Am J Physiol Cell Physiol; 2003 Nov; 285(5):C1150-60. PubMed ID: 12839838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation.
    Vorgerd M; Ricker K; Ziemssen F; Kress W; Goebel HH; Nix WA; Kubisch C; Schoser BG; Mortier W
    Neurology; 2001 Dec; 57(12):2273-7. PubMed ID: 11756609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-3 gene mutation in Japanese with rippling muscle disease.
    Yabe I; Kawashima A; Kikuchi S; Higashi T; Fukazawa T; Hamada T; Sasaki H; Tashiro K
    Acta Neurol Scand; 2003 Jul; 108(1):47-51. PubMed ID: 12807393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic variability associated with Arg26Gln mutation in caveolin3.
    Fee DB; So YT; Barraza C; Figueroa KP; Pulst SM
    Muscle Nerve; 2004 Sep; 30(3):375-8. PubMed ID: 15318349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.
    Betz RC; Schoser BG; Kasper D; Ricker K; Ramírez A; Stein V; Torbergsen T; Lee YA; Nöthen MM; Wienker TF; Malin JP; Propping P; Reis A; Mortier W; Jentsch TJ; Vorgerd M; Kubisch C
    Nat Genet; 2001 Jul; 28(3):218-9. PubMed ID: 11431690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
    Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
    Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.
    Galbiati F; Engelman JA; Volonte D; Zhang XL; Minetti C; Li M; Hou H; Kneitz B; Edelmann W; Lisanti MP
    J Biol Chem; 2001 Jun; 276(24):21425-33. PubMed ID: 11259414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolae and caveolin-3 in muscular dystrophy.
    Galbiati F; Razani B; Lisanti MP
    Trends Mol Med; 2001 Oct; 7(10):435-41. PubMed ID: 11597517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity.
    Sunada Y; Ohi H; Hase A; Ohi H; Hosono T; Arata S; Higuchi S; Matsumura K; Shimizu T
    Hum Mol Genet; 2001 Feb; 10(3):173-8. PubMed ID: 11159934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases.
    Woodman SE; Sotgia F; Galbiati F; Minetti C; Lisanti MP
    Neurology; 2004 Feb; 62(4):538-43. PubMed ID: 14981167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.
    Minetti C; Sotgia F; Bruno C; Scartezzini P; Broda P; Bado M; Masetti E; Mazzocco M; Egeo A; Donati MA; Volonte D; Galbiati F; Cordone G; Bricarelli FD; Lisanti MP; Zara F
    Nat Genet; 1998 Apr; 18(4):365-8. PubMed ID: 9537420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CAV3 microdeletion differentially affects skeletal muscle and myocardium.
    Finsterer J; Stoellberger C
    Neurology; 2004 Jul; 63(1):195; author reply 195. PubMed ID: 15249648
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristic findings of skeletal muscle MRI in caveolinopathies.
    Ishiguro K; Nakayama T; Yoshioka M; Murakami T; Kajino S; Shichiji M; Sato T; Hino-Fukuyo N; Kuru S; Osawa M; Nagata S; Okubo M; Murakami N; Hayashi YK; Nishino I; Ishigaki K
    Neuromuscul Disord; 2018 Oct; 28(10):857-862. PubMed ID: 30174172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.
    Galbiati F; Volonte D; Minetti C; Chu JB; Lisanti MP
    J Biol Chem; 1999 Sep; 274(36):25632-41. PubMed ID: 10464299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.
    Minetti C; Bado M; Broda P; Sotgia F; Bruno C; Galbiati F; Volonte D; Lucania G; Pavan A; Bonilla E; Lisanti MP; Cordone G
    Am J Pathol; 2002 Jan; 160(1):265-70. PubMed ID: 11786420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.